Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Enterprise Value: 2015-2024

Historic Enterprise Value for Collegium Pharmaceutical (COLL) over the last 10 years, with Dec 2024 value amounting to $761.2 million.

  • Collegium Pharmaceutical's Enterprise Value fell 27.42% to $816.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $233.7 million, marking a year-over-year increase of 4.08%. This contributed to the annual value of $761.2 million for FY2024, which is 9.81% up from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Enterprise Value is $761.2 million, which was up 9.81% from $693.2 million recorded in FY2023.
  • Collegium Pharmaceutical's Enterprise Value's 5-year high stood at $761.2 million during FY2024, with a 5-year trough of $459.3 million in FY2021.
  • In the last 3 years, Collegium Pharmaceutical's Enterprise Value had a median value of $693.2 million in 2023 and averaged $686.5 million.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Enterprise Value fell by 11.43% in 2021, and later soared by 31.76% in 2022.
  • Collegium Pharmaceutical's Enterprise Value (Yearly) stood at $518.6 million in 2020, then fell by 11.43% to $459.3 million in 2021, then soared by 31.76% to $605.2 million in 2022, then increased by 14.55% to $693.2 million in 2023, then grew by 9.81% to $761.2 million in 2024.